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Abstract
Background: Posttraumatic stress disorder (PTSD) after childhood abuse (CA) is often related to severe co-occurring
psychopathology, such as symptoms of borderline personality disorder (BPD). The ICD-11 has included Complex PTSD
as a new diagnosis, which is defined by PTSD symptoms plus disturbances in emotion regulation, self-concept, and
interpersonal relationships. Unfortunately, the empirical database on psychosocial treatments for survivors of CA is
quite limited. Furthermore, the few existing studies often have either excluded subjects with self-harm behaviour and
suicidal ideation — which is common behaviour in subjects suffering from Complex PTSD. Thus, researchers are still
trying to identify efficacious treatment programmes for this group of patients.
We have designed DBT-PTSD to meet the specific needs of patients with Complex PTSD. The treatment programme is
based on the rules and principles of dialectical behavioural therapy (DBT), and adds interventions derived from cognitive
behavioural therapy, acceptance and commitment therapy and compassion-focused therapy. DBT-PTSD can be provided
as a comprehensive residential programme or as an outpatient programme. The effects of the residential programme
were evaluated in a randomised controlled trial. Data revealed significant reduction of posttraumatic symptoms, with
large between-group effect sizes when compared to a treatment-as-usual wait list condition (Cohen’s d = 1.5).
The first aim of this project on hand is to evaluate the efficacy of the outpatient DBT-PTSD programme. The second aim is
to identify the major therapeutic variables mediating treatment efficacy. The third aim is to study neural mechanisms and
treatment sensitivity of two frequent sequelae of PTSD after CA: intrusions and dissociation.
Methods: To address these questions, we include female patients who experienced CA and who fulfil DSM-5 criteria for
PTSD plus borderline features, including criteria for severe emotion dysregulation. The study is funded by the German
Federal Ministry of Education and Research, and started in 2014. Participants are randomised to outpatient psychotherapy
with either DBT-PTSD or Cognitive Processing Therapy. Formal power analysis revealed a minimum of 180 patients to be
recruited. The primary outcome is the change on the Clinician-Administered PTSD Scale for DSM-5.
Discussion: The expected results will be a major step forward in establishing empirically supported psychological
treatments for survivors of CA suffering from Complex PTSD.
Trial registration: German Clinical Trials Register: registration number DRKS00005578, date of registration 19 December
2013.
Keywords: Childhood abuse, Complex posttraumatic stress disorder, Dialectical behavioural therapy, Randomised
controlled trial
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Background
Sequelae of child abuse
Childhood abuse (CA) is a serious and pervasive problem
worldwide, with childhood sexual abuse reported by 18%
of women and 8% of men [1], and childhood physical
abuse by 22 and 25%, respectively [2]. Adult survivors of
CA often live with significant consequences, including
psychiatric disorders. The World Mental Health Survey
including representative surveys in 21 countries found
that childhood adversities account for 30% of all mental
disorders across countries [3]. Cohort studies [4–8] and
epidemiological studies [3, 9, 10] revealed the highest odds
ratios for affective disorders, substance related disorders,
borderline personality disorder (BPD) and posttraumatic
stress disorder (PTSD). The latter is often associated with
emotion dysregulation, dissociative symptoms, aversive
self-concepts, and interpersonal difficulties. This results in
a relatively high comorbidity: Between 30 and 60% of pa-
tients with BPD suffer from co-occuring PTSD and be-
tween 17 and 30% of patients with PTSD meet the criteria
for BPD [11–15]. These co-occuring symptoms have been
described under the terms Complex PTSD (cPTSD) and
Disorders of Extreme Stress Not Otherwise Specified
(DESNOS). Both the DSM-5 [16] and the ICD-11 [17]
have taken the symptoms of cPTSD into account. The
DSM-5 added symptoms to the PTSD diagnosis that have
frequently been viewed as symptoms of cPTSD, such as
distorted beliefs about self and others, dissociation, and
reckless behaviour. The ICD-11 [17] includes a distinct
cPTSD diagnosis that comprises the three main symptom
clusters of PTSD along with enduring disturbances in the
domains of affect, self, and interpersonal relationships.
Several studies support the ICD-11 distinction between
PTSD and cPTSD, and have found that a history of CA is
strongly associated with the latter [18, 19].
Economic costs of PTSD and co-occurring BPD
Apart from the individual suffering, economic costs for treat-
ment and functional impairment (e.g., unemployment) are a
heavy burden for the health care system. Data from our
group on economic aspects of patients with PTSD and se-
vere emotion dysregulation like BPD, in Germany indicate
average direct and indirect costs of about €28.000 per patient
(2/3 direct treatment costs) for a period of 1 year, and further
indicate that within the German health system, co-morbidity
as well as severity of PTSD is related to higher direct costs
for healthcare [20, 21].
Psychosocial treatments
Cognitive-behavioural therapies have been shown to be
efficacious in treating adults with PTSD in general [22,
23]. The recently revised Clinical Practice Guideline for
the Management of PTSD [24] strongly recommends
the use of individual, trauma-focused psychotherapies
that have a primary component of exposure and/or cog-
nitive interventions. However, there has been little study
of the efficacy of these therapies for PTSD related to CA
in general and specifically in patients with co-occuring
BPD-symptoms. Meta-analyses specifically studying psy-
chological treatment effects in patients with PTSD re-
lated to CA yielded smaller effect sizes (medium effect
size d = 0.7; [25]) and lower recovery rates in CA-related
PTSD [26] than compared to those studies, that in-
cluded all types of PTSD. Furthermore, studies on
CA-related PTSD often excluded patients with substance
abuse, dissociative disorders, BPD and suicidality [26].
There is a mixed data base on the impact of CA on
PTSD treatment outcome. A randomised controlled trial
(RCT) of eye movement desensitization and reproces-
sing (EMDR) found that PTSD related to a childhood
trauma compared to PTSD related to an adulthood
trauma was associated with less improvement and a
lower remission rate [27]. Another study, which com-
pared prolonged exposure (PE) with stress inoculation
training, also found that patients with a childhood
trauma showed less improvement [28]. However, several
other studies found no evidence supporting a negative
impact of CA on the treatment outcome after PE,
EMDR and cognitive processing therapy (CPT) [29–33].
A most recent metaregression-analysis included 51 RCTs
and suggested that childhood trauma was associated with
a poorer response to psychological therapy (Karatzias,
Murphy, Cloitre, Bisson, Roberts, Shevlin: Psychological
interventions for ICD-11 complex PTSD symptoms: sys-
tematic review and meta-analysis, submitted).
There is also a mixed data base regarding the impact
of a co-occuring BPD. Five studies documented no sig-
nificant effects of co-morbid BPD on treatment outcome
[34–38]. Notably, three studies of these excluded pa-
tients with current self-injurious behaviour [34–36]. One
study, which compared individual cognitive-behavioural
therapy to individual present-centered therapy for female
survivors of childhood sexual abuse (CSA) found that all
patients with a co-occurring BPD diagnosis dropped out
of cognitive-behavioural therapy [39].
Thus, researchers are still trying to identify treatment
models for adult survivors of CA with concurrent severe
emotional dyscontrol or severe dysfunctional behaviours.
Currently, the American Psychological Association [24]
and the US Department of Veterans Affairs and Depart-
ment of Defense [40] considers four psychological treat-
ments for PTSD to have strong research support. Among
these empirically evaluated treatments, one of the cur-
rently most promising approaches is CPT [41, 42]. CPT
was originally developed as a group treatment for rape vic-
tims. Originally it comprised two components: cognitive
interventions and written trauma accounts [43]. Chard
[44] adapted CPT for victims of CSA by combining
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individual and group treatment. In an RCT comparing 17
weeks of this treatment to a wait-list control, the treat-
ment was found to be highly efficacious [44]. However,
this study did not report data for patients with BPD.
Resick et al. [45] conducted an RCT to separate out the ef-
ficacy of the two components of CPT, and found that a
treatment consisting of only the cognitive interventions
was as successful in treating PTSD as was the combin-
ation of cognitive and exposure interventions, with lower
dropout rates. Accordingly, the written trauma accounts
constitute no standard intervention of CPT anymore [42].
However, since personality disorders were not assessed
in the RCT by Resick et al. [45], and since only 38% of
the participants defined CSA as their worst traumatic
event it remains unclear whether these treatment results
can be generalised to patients with cPTSD related to
CA. Moreover, the data revealed only small effects on
typical problems of patients with cPTSD, such as diffi-
culties in anger control and re-victimisation [46].
The International Society of Traumatic Stress Studies
(ISTSS) recommends in its guidelines for the treatment
of cPTSD the use of phase-based, modular treatments
including modules to improve emotion regulation and
traumatic memory processing [47]. One of the empiric-
ally best supported treatment for emotion dysregulation
is dialectical behavioural therapy (DBT). However, in the
absence of a specific protocol for treating co-occurring
PTSD, only a minority of BPD clients with co-occurring
PTSD who underwent 1 year of DBT treatment achieved
full remission from PTSD [48, 49]. Accordingly, several
treatments combining DBT and trauma-focused
methods have been developed. Harned et al. [49, 50]
added a PE protocol after successful stage I standard
DBT. In a first open-trial study by Harned et al. [50], 13
BPD patients with PTSD received a trauma-focused
exposure-based treatment in addition to ongoing stand-
ard outpatient DBT once they had achieved control over
so-called stage I treatment targets such as self-injurious
behaviour. Intent-to-treat analyses revealed significant
improvement in posttraumatic symptoms and in most
secondary outcomes, with medium to large pre-post ef-
fect sizes. In a second pilot RCT, Harned et al. [49] com-
pared standard DBT (n = 9) with DBT + PE (n = 17).
Eight of the 17 patients randomised to the DBT-PE arm
started the PE protocol and only six patients (35%) com-
pleted the treatment. The sample size was too small for
a sound interpretation of differential treatment effects.
Cloitre et al. [51] reported the benefits of DBT-derived
skills training as a precursor to PE as compared to sup-
portive counselling as a precursor to PE in adults with
PTSD after CA. The study yielded first evidence that a
phase-based treatment including emotion regulation
training might be superior to PE. However, the lack of a
PE alone condition in this study precludes drawing
conclusions about the relative benefits of the
phased-treatment approach over state of the art PTSD
treatment. Despite the promising results of these modi-
fied (phase-based) treatments, no treatment has yet been
directly compared with a first-line PTSD treatment such
as CPT.
DBT-PTSD
As outlined above, none of established treatments met the
requirements for a sufficient therapeutic approach for a
population suffering from PTSD and co-occuring severe
problems with emotion regulation, self-concept and social
interaction. Accordingly, we developed DBT-PTSD to spe-
cifically address the needs of this group of patients.
DBT-PTSD was designed to include severely sick patients,
suffering from chronic CA-related cPTSD along with se-
vere problems in emotion regulation, ongoing
self-harm behaviour, suicidal ideations and dissociative
symptoms, negative self-concepts with high levels of guilt,
shame, self-contempt and interpersonal problems.
DBT-PTSD has been developed as a disorder-specific
multi-modular treatment concept with clear treatment al-
gorithms. The backbone of DBT-PTSD, i.e. the principles,
the rules, the majority of interventions and, in particular,
the benevolent, challenging, “dialectical” attitude, are de-
rived from DBT [52–54]. This concept, originally evalu-
ated for chronic suicidal patients with BPD, includes clear
structures and dynamic hierarchisation of treatment fo-
cuses. An additional significant element of DBT is the
procurement of so-called “skills”. These are short and pre-
cise mental self-instructions and guidelines for action that
aim to interrupt and modify automated, intrapsychic pro-
cessing as well as behavioural patterns. The skills can be
applied to manage extreme conditions of stress, tension
and dissociation without problematic behaviour, to modu-
late maladaptive emotions and to modify automated cog-
nitions. All of this plays a critical role in the successful
treatment of cPTSD. Because trauma-specific interven-
tions are not described in more detail in the standard
DBT, we supplemented trauma-specific cognitive [55] and
exposure-based techniques as described by Ehlers [55],
and Foa et al. [56]. However, we had to consider, that
within this group of patients, in-sensu exposure as de-
scribed/applied in PE often goes with intense dissociative
features, which hamper emotional learning [57–60] and
therefore have negative impact on treatment outcome
[61]. Accordingly, we modified the standard PE procedure
[56] by adding anti-dissociative skills (skills-assisted ex-
posure). Clinical experiences with patients with a history
of CA have shown that early established cognitive-
affective schemes often cannot be completely modified
even by successful therapy. Therefore, it seems to be im-
portant that patients learn a better approach to these au-
tomated processes and implement a profound
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meta-cognitive and meta-emotional awareness, which en-
ables them to process these automatic thoughts and emo-
tional patterns from a more distanced perspective, learn
to control the emotion driven action tendencies and re-
place them by functional behaviour. Acceptance and com-
mitment therapy [62] provides valuable interventions
here. Furthermore, this treatment consists of many helpful
interventions for the recognition and implementation of
values and therewith the improvement of the quality of
life. Precisely because the self-concept is often character-
ized by trauma-related emotions such as shame or guilt,
disgust and self-hate, many patients have significant diffi-
culties dealing with themselves in a sympathetic and
self-valuing manner – which is also frequently reflected in
problems relating to interpersonal issues. In addition to
the DBT-concept of teaching self-validation, in
compassion-focused therapy [63], these difficulties are ad-
dressed through the training of a compassionate perspec-
tive towards oneself and other people. Here, compassion
is defined as sensitivity towards one’s own suffering and
that of other persons with a deep commitment to mitigate
the suffering, and this thereby encompasses both an em-
pathic, attentive and a purposeful, powerful component.
All of these sources of DBT-PTSD are, in turn, anchored
in the principles of mindfulness. Because many trauma-
tized patients experience longer mindfulness meditations
as unpleasant and encumbering at least at the beginning
of the treatment, skills-based mindfulness is facilitated in
DBT-PTSD. In this, the psychological active principles of
mindfulness are portioned into individual skills suitable to
a daily routine and shorter mindfulness exercises without
relying on formal meditation as a necessary experience.
DBT-PTSD is divided into seven topical treatment
phases (Fig. 1) which are spread out over 12 weeks in
the inpatient setting and over 1 year with up to 45 indi-
vidual therapy sessions in the outpatient setting. Every
treatment phase includes mandatory and voluntary treat-
ment modules. This modular approach allows to tailor
the treatment to the diverse symptom constellations of
individuals suffering from cPTSD. Manualized “if-then
rules” help the therapists to decide which of the suitable
modules is being used in the individual case.
Independent of the distinct treatment phases, all indi-
vidual session agendas are determined by hierarchically
ordered treatment targets, as follows: 1) reduce
imminent life-threatening behaviours, 2) reduce behav-
iours interfering with treatment maintenance or pro-
gress. Skills training is provided during the individual
therapy: Skills have been modified for the specific needs
of patients with cPTSD, and include: 1) mindfulness and
compassion skills, 2) distress tolerance skills, 3) emotion
regulation skills, and 4) regaining a life worth living
skills. Phone consultations with the individual therapist
focus on crisis intervention. Consultation team meetings
are aimed at maintaining treatment fidelity. These meet-
ings are conducted by the therapists following guidelines
in the treatment manual.
Diagnostics, indication of treatment, information on
the treatment concept and the empirical database occur
before the treatment begins (Pre-Treatment Phase). If
the patient appears sufficiently motivated to start the
treatment, a non-suicide contract will be concluded. In
return, a crisis intervention telephone hotline is guaran-
teed to them.
In the first phase (“Commitment”), a brief, struc-
tured interview records the active, dysfunctional behav-
iour pattern at the time. The therapist establishes a crisis
and emergency plan. A short introduction to the skills
concept also follows and, in this case in particular, an
introduction to mindfulness. A special feature lies here
in the development of a “compassionate-supporting self”
(compassionate mindfulness). The patients develop this
understanding by listening daily to imaginative
self-instructions that have been recorded by their thera-
pists. Specifically in this commitment phase, a rough
orientation of time, manner and frequency of the trau-
matic experiences should be compiled, including the
threats that the child was exposed to for reporting the
trauma.
In the second phase (“Trauma Model and Motiv-
ation”), the focus is on establishing a conclusive model
of how PTSD develops, is preserved and can be treated.
For this, the model of the “old path and the new path”
with the trauma network and the mental and
behaviour-related avoidance and escape strategies is gen-
erated. The patients should understand how strongly
PTSD influences their lives and how trauma-related
automatic thoughts and emotions prevent them from
developing a meaningful life. The patients become
acquainted with their typical avoidance and escape strat-
egies and the related short- and long-term conse-
quences. Moreover, they acquire a certain understanding
for the mechanisms and effectiveness of exposure-based
interventions (the brain must learn to differentiate be-
tween the past and the present). Based on this, therapist
and patient develop operationalised, realistic and meas-
urable treatment goals that are significant for the indi-
vidual value system of the patient. Precisely because
many patients with cPTSD have experienced severe dis-
appointments from primary reference persons, we as-
sume that these interpersonal experiences might repeat
themselves in the therapeutic relationship in the context
of transference processes and thereby hamper the co-
operative work. In order to counteract this problem, we
have taken up an idea from McCullough [64] and oper-
ate in advance an analysis of the experience with the
most important formative significant others and their
potential effect on the therapeutic relationship. The
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second treatment phase is completed with an analysis of
potential disorder-maintaining conditions and individual
fears regarding the therapy.
At the end of this second treatment phase, the patients
and their therapists present the treatment plan together
to the consultation team, mutually discuss the prospects
of success as well as possible required support and ob-
tain the permission to enter the third therapy phase –
and, with it, permission to begin the preparation for the
exposure phase.
In the third phase (“Skills and Cognitive Ele-
ments”), the therapists analyse behaviour-related (e.g.,
self-harm) and emotional (e.g., guilt, shame, dissociation)
escape strategies and convey the appropriate functional
skills. The patients learn to recognise and rate the level
of internal tension and learn to identify early signals of
beginning dissociative states and to reduce them with
strong sensory stimuli or physiological distraction (ice
packs, ammonia, chili, juggling, eye-movement, and bal-
ancing). They also become familiar with the fundamental
evolutionary significance of emotions such as guilt,
shame, contempt and disgust and learn to recognise and
modulate them.
The exposure-based processing of trauma-associated
memories and emotions are at the core of the fourth
phase (“Skills-Assisted Exposure”). To maintain the
level of aversive arousal within a tolerable range and to
prevent dissociative symptoms, the exposure occurs in
accordance with the principle of the skills-assisted ex-
posure. In doing so, the application of skills helps estab-
lishing a balance between activation of trauma-
associated emotions and awareness of the present mo-
ment. The primary objective of this intervention is the
exposure to the trauma-associated primary emotions
such as powerlessness, disgust, anxiety and pain. In con-
formity with the theory of inhibitory learning, the inter-
vention results in a reduction of these feelings which are
not adequate for the present moment and in the correc-
tion of unrealistic fears in terms of a behaviour experi-
ment (e.g., “I will go crazy if I allow this memory.”).
Methodically, DBT-PTSD proceeds as follows: First the
therapists and patients establish the so-called index
trauma together. It has proved reasonable to select the
incident here that is currently bound to the most fre-
quent and most distressing intrusions and nightmares.
During the later course of the phase, additional stressful
Fig. 1 Treatment phases of DBT-PTSD with dynamic focus hierarchy
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memories can then be the focus. In the second step, the
most critical fears and concerns are processed with re-
spect to exposure: “I will go crazy.”, “I won’t survive it”.
These fears are first substantiated and questioned in so-
cratic dialogue. The actual exposure phase begins when
the patients first write down the incident including
thoughts and feelings that occurred during the event.
This script is first read aloud in the therapy session.
Then the repeated in-sensu exposure follows. In this, the
therapists essentially strive to achieve a high emotional
activation and to actively interrupt dissociative symp-
toms. Prototypically, the patient relates the traumatic ex-
perience during the exposure in the first person, in the
present, with closed eyes. Intermittently, the exposure is
interrupted by the therapists to create the sensory refer-
ence to reality: “What is the difference between then and
now? How do you see this, how do you feel this?”. In the
therapy session, the memory should be imagined at least
two times. To ensure this, “hot spots” are selected and
imagined. It is also helpful to ask at the end of the “hot
spots” if the patient has reported anybody to this event
and, if not, what prevented them from doing so. Often
non-validating rejection by close caregivers is experi-
enced as highly traumatic and should also be exposed.
Between the therapy sessions, the patients listen to the
audio recordings of the exposure every day at home. We
have developed and evaluated an app that can easily im-
pede dissociate symptoms during the exposure and can
also monitor the processes of the emotions (decline in
guilt, shame, disgust, etc.) (https://morpheus.-
deuschel-schueller.de). In most of the cases, a significant
reduction in symptoms (decline in the frequency and
distress from intrusions and flashbacks; revision of guilt
and shame) sets in within 5 to 6 exposure sessions. Then
the focus can be adjusted to other incidents in which the
handling of generally requires less time and energy.
The fifth phase (“Radical Acceptance”) is linked to
the exposure phase with exercises in acceptance and
embracing what has been experienced. The majority
of patients are still at odds with their past after the
exposure phase and have marked difficulties in
accepting this as unalterable and as an incident that
happened. Patients often show concerns that accept-
ance could signify that the incidents were not so bad
or that they have to forgive the perpetrators. More-
over, they show emotional difficulties in parting from
old illusions: “If I had only behaved appropriately, this
would not have happened and I would have achieved
an attentive, loving relationship with my father /
mother”. This phase is also about ending the illusion-
ary relationship with primary caregivers and making
room for a mature, revised and realistic consideration.
Embracing what has been experienced opens up space
for grief which needs its own time.
In the sixth phase (“A Life Worth Living”), the pa-
tients explore new areas of life or actively seek improve-
ments to those factors which stand in the way of a
meaningful life worth living. For patients with a history
of CA, topics such as partnership and relationships,
physical experience and sexuality as well as changes in
the professional life are almost always significant. Pre-
cisely because not only the trauma-associated experience
and behaviour but also the entire self-concept is to be
accounted for in this therapy programme with very in-
tense changes, the patients need structured support in
this phase to develop a new living concept. Methodically,
we rely on the model of the “old and new path” in this
phase.
The seventh and final phase (“Farewell”) follows
some predefined rules, since fear of abandonment is an
intrinsic problem of patients with cPTSD. However, end-
ing a therapeutic relationship after such an intense phase
of cooperation naturally is a bit painful (for both, therap-
ist and patient).
In summary, DBT-PTSD aims to help patients i) re-
duce their avoidance of trauma-associated primary emo-
tions such as fear, disgust, pain, and powerlessness, ii)
question non-justified trauma-related emotions such as
guilt, shame, and self-contempt, and iii) radically accept
trauma-related biographic facts. To successfully reduce
avoidance of trauma-associated emotions, exposure-
based techniques including control of escape strategies
are required. Accordingly, patients learn to identify their
typical cognitive, emotional, and behavioural escape
strategies in response to trauma-related stimuli, and to
use DBT skills to control these. The exposure protocol
allows the patient to control the intensity of memory ac-
tivation, and balances the vividness of trauma memories
with the awareness of being in the (non-dangerous)
present, by using skills during exposure sessions and ex-
posure homework (skills-assisted exposure). Finally, the
treatment focuses on relevant psychosocial aspects in-
cluding work and partnership.
The empirical base of DBT-PTSD
Following the usual process of evaluating a new treat-
ment, as a first step, we carried out a non-controlled
clinical pilot trial on residential DBT-PTSD treatment
on 29 women who suffered from PTSD after CA and at
least one other co-occurring diagnosis [65]. An effect
size of Cohen's d = 1.22 on the Posttraumatic Diagnostic
Scale (PDS; [66]) was found between baseline and the
follow-up 6 weeks after the end of the 12-week
programme. Effect sizes for secondary outcomes ranged
from medium to large. The results suggested that
DBT-PTSD is a very promising treatment for reducing
severe PTSD after CA.
Bohus et al. Borderline Personality Disorder and Emotion Dysregulation             (2019) 6:7 Page 6 of 16
Next, we conducted a RCT in which women (N = 74)
diagnosed with PTSD after CA plus at least one of the
following additional diagnoses/symptoms: at least 4
DSM-IV criteria of BPD, current major depressive dis-
order, eating disorder, or alcohol and drug abuse were
randomised to either the 12-week residential DBT-PTSD
programme or a treatment-as-usual waiting
list (TAU-WL) [67]. The two primary outcomes were
scores on the Clinician-Administered PTSD Scale
(CAPS; [68]) and on the PDS [66]. All measurements
were done by blind raters. Only 6% of the DBT-PTSD
group (2 out of 36) discontinued the treatment prema-
turely. Hierarchical linear models yielded statistically sig-
nificant group*time effects, indicating a more
pronounced improvement in the DBT-PTSD group
compared to the TAU-WL, with large effect sizes.
Between-group effect sizes were large for the CAPS
(Hedges’s g = 1.57), PDS (g = 1.27), Global Assessment of
Functioning (GAF, [69]; g = 1.31), and Beck Depression
Inventory-II (BDI-II, [70]; g = 1.13). No patient in the
DBT-PTSD group showed worsening of posttraumatic
symptoms or exaggerated dysfunctional behaviour [67,
71]. Neither BPD symptom severity, the number of BPD
criteria, nor self-harm behaviour had a significant influ-
ence on treatment outcome. Our findings provided clear
evidence for the efficacy, high tolerability, and safety of
the newly developed DBT-PTSD under residential
conditions.
In preparation for the trial on hand, we have adapted
the DBT-PTSD manual to outpatient conditions.
DBT-PTSD now consists of a 1 year multi-component
treatment providing up to 45 sessions à 50min (37.5 h
hours in total) of individual therapy (and telephone con-
sultation as needed) plus up to 3 additional booster ses-
sions during the following 3 months. These booster
sessions mainly focus on implementation of relevant
treatment aspects in daily live. We have tested the man-
ual in a pre-post pilot study that enrolled 20 patients
with PTSD after CA plus at least 4 BPD criteria, and
found similar results to those obtained under residential
conditions (effect size CAPS: Cohen’s d = 1.5) [72].
Unlike current state-of-the-art treatments for PTSD,
which typically consist of 12 to 16 sessions, we decided
on a longer treatment duration and more treatment ses-
sions as justified by the following:
a) The included patients suffer not only from PTSD
but also from severe emotional dysregulation and
serious dysfunctional behavioural patterns including
self-harm behaviour. Standard DBT programmes
that do not focus on PTSD usually last at least 1
year [73–75];
b) The successful residential programme consists of
twice-weekly 45-min sessions of individual
treatment (a total of 23 sessions over the 12 weeks)
plus the following weekly group treatments: 90 min
of skills training (11 sessions in total), 60 min of
group intervention focusing on self-esteem (8 sessions
in total), three 25 min mindfulness sessions (35 sessions
in total), as well as 60 min of PTSD-specific
psychoeducation (11 sessions in total) and three
90- min non-specific weekly group interventions
(music therapy, art therapy).
In the trial on residential DBT-PTSD, we found an
average reduction of PTSD symptoms as assessed by the
CAPS from 88 at admission to 55 at discharge [67]. Des-
pite this clinically significant reduction in the primary
outcome, many of the patients needed further psycho-
therapy after discharge. Taken together, 45 sessions of
outpatient treatment is a minimum, and is justified for
scientific and ethical reasons. Furthermore, the German
health care system in general covers the costs for up to
80 sessions of behaviour therapy. Designing a short-term
therapy for this group of severely disturbed patients
would be unrealistic and would not fit into the frame of
the German health care system. To facilitate transfer
into routine conditions, we further decided to provide
all psychotherapeutic sessions in an individual format.
This allows to disseminating these treatments to rural
regions which have little access to psychotherapeutic
supply.
Cognitive processing therapy (CPT)
We chose CPT as an adequate active control condition.
In close cooperation with P. Resick (Duke University,
Durham, USA), the developer of this treatment, we have
adapted the established protocol for CPT (cognitive only
version) to a 1 year outpatient individual therapy
programme comprising up to 45 sessions plus up to 3
additional booster sessions during the following 3
months. Thus, dosage and frequency of both treatments
are equal.
The protocol has been translated and has been ap-
proved by Dr. Resick, who serves as a cooperation part-
ner and supervisor. We have further translated and
adapted the rating for therapeutic adherence for CPT on
the basis of the ones used by Resick et al. [45, 76].
To ensure treatment fidelity therapists receive 1.5 h
per week team consultation with local supervisors. In
addition, the local supervisors have monthly case-con-
sultations with the treatment developer Dr. Resick.
Individual sessions follow a session-by-session proto-
col. In addition to building an effective therapeutic alli-
ance, the first 4 sessions aim to obtain a detailed case
history, patient’s specific problem behaviour, and emer-
gency plans. The next 12 sessions contain the original 12
CPT core sessions, starting with psychoeducation about
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PTSD and the treatment rationale. After the patient has
written an impact statement as to why the trauma has
happened and how it affected her beliefs, cognitive re-
structuring is applied with regard to guilt and denial.
Then, worksheets are introduced step by step which are
intended to support the patient in identifying and chan-
ging other dysfunctional trauma-related beliefs (the
so-called stuck-points) regarding safety, trust, control
and power, self-esteem, and intimacy. From session 17
onwards, the content of the sessions is derived from the
patient’s individual stuck point log. After working on the
index trauma, and writing a second impact statement,
other traumatic incidents can be the treatment focus.
Towards the end of the treatment, other goals of the pa-
tient (positive activities, social relationships, vocational
training or work issues) can be addressed using the
already established cognitive techniques.
Design
Work plan
The three goals of this collaborative research group are:
1) To evaluate the efficacy and effectiveness of a newly
developed outpatient psychotherapy programme
tailored specifically for patients suffering from
cPTSD after childhood physical and sexual abuse
(Main project)
2) To assess the role of treatment integrity
(therapeutic adherence and competence) for
treatment outcome of DBT-PTSD and CPT
(Adjunct project I)
3) To study the impact of successful treatments on the
neurophysiological underpinnings of dissociation
and intrusions (Adjunct project II)
Main project
Hypotheses
1) Improvement of PTSD symptoms will be superior
in DBT-PTSD as compared to CPT.
2) The superiority of DBT-PTSD over CPT is related
to the severity of BPD symptoms at baseline.
Additional analyses
The collected data will enable us to additionally test po-
tential moderator variables for both, general and differ-
entiated treatment response: a) Client variables
including severity of CA, age at the onset and duration
of CA, pre-treatment severity of PTSD and dissociation,
co-occurring depressive disorder, current age, and edu-
cational level; b) Therapist variables including length of
experience and gender.
Health care costs
As cPTSD is related to very high health care costs, we
will also address this aspect. Direct and indirect costs
will be compared across treatments and will be further
compared with costs related to other epidemiologically
relevant mental disorders. The reference time frames
will be 1 year before the start of the treatments, at the
end of treatments, and at 1 year follow-up. State of the
art methodology will be applied (e.g., [77–80]), including
a questionnaire and a structured interview to assess
health care costs.
Inclusion criteria
We include female subjects between the ages of 18 and
65 who have a primary diagnosis of DSM-5–defined
PTSD related to childhood sexual abuse or childhood
physical violence before the age of 18. In addition, the
patients have to meet at least 3 DSM-5 criteria for BPD
(including criterion 6, affective instability). Furthermore,
the patients have to be available for 1 year of outpatient
treatment with no scheduled absence of more than 4
weeks, have to understand the implications related to
the participation in a clinical trial, and have to give their
written informed consent prior to randomisation.
Exclusion criteria
Exclusion Criteria are a lifetime diagnosis of schizophrenia
or bipolar I disorder, mental retardation, severe psycho-
pathology requiring immediate treatment in a different
setting (such as acute alcohol withdrawal syndrome, or
BMI < 16.5), current substance dependence without ab-
stinence within the last 2month, life-threatening suicide
attempts as assessed by the Severe Behaviour Dyscontrol
Interview (SBDI, [81]) within the last 2months, medical
conditions contradicting exposure protocol (e.g., severe
cardiovascular disorder), pregnancy, currently severe
instable life situations (e.g., homelessness, or ongoing
victimisation by the perpetrator), or treatment with
CPT or DBT-PTSD within the last year. Patients with
ongoing self-harm or high-risk behaviours are ac-
cepted in the study.
Randomisation and blinding procedures
Before the start of the study, patients who meet the eligi-
bility criteria are randomised in 1:1 ratio to either
DBT-PTSD or CPT. Concealed assignment to the treat-
ment groups is assured by using an external, web-based
randomisation service (http://randomizer.at, University
of Graz, Austria). All persons involved in the diagnostics
and ratings are blinded with respect to the group
assignment.
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Crisis management
Both interventions develop safety plans at treatment
start, and employ active crisis intervention when needed.
Similar to standards of care, therapists provide on-call
after-hours service via area crisis services. Patients in
both groups have access to emergency services when
viewed as necessary by therapists in the respective con-
ditions. Inpatient services are readily available across
conditions and across sites.
Hospitalisation policy
Because of the nature of the population, some patients
may require treatment in a psychiatric hospital, either at
their own request or due to the concerns of care pro-
viders (usually due to high acute suicide risk). No out-
patient therapist will serve in a responsible position for
any patient (e.g., attending) during inpatient treatment.
Study treatment will be terminated when patients are
hospitalised for more than 2 weeks.
Psychotropic medication protocol
There is no established pharmacological treatment
protocol for PTSD after CA. On the other hand, taper-
ing patients off medication would restrict recruitment to
a small number of patients with less severe pathology
and would be at the cost of external validity. We decided
to track week-by-week medications and medication
changes in order to document any difference in medica-
tion management across conditions. The purpose of the
study is not to evaluate the efficacy of a combination of
psychotherapy and a psychopharmacologic algorithm,
but rather to evaluate psychotherapy interventions under
conditions similar to those encountered in the
community.
Dropout policy
Besides patients prematurely terminating therapy, any
patient who misses 6 consecutively scheduled weeks of
individual therapy or stays longer than 2 weeks in a psy-
chiatric hospital will be considered a drop-out from
treatment. This rule was instituted because it can be
very difficult to know exactly when an emotionally dys-
regulated patient has actually dropped out of therapy.
Often, patients miss sessions because of mood swings,
discouragement, or interfering day-to-day hassles, but
they do not mean to drop out of treatment and they
often change their minds within a short period of time.
This drop-out rule will be explained to patients during
the first session of individual therapy. It is conceivable
that some patients achieve the treatment goals (full
symptomatic remission) and want to terminate the treat-
ment prior to 1 year of treatment. The study protocol
foresees the possibility of an early remission: No longer
fulfilling the diagnostic criteria of PTSD, as assessed by
the Clinician-Administered PTSD Scale for DSM-5
(CAPS-5; [82, 83]), as well as the approval by the pa-
tient, the therapist and the supervisor. Patients who have
achieved an early remission are not considered having
dropped out of the study.
Protocols to prevent cross-contamination between DBT-
PTSD and CPT conditions
To reduce contamination, CPT and DBT-PTSD are not
provided by the same therapists. Treatment fidelity will
be supported by regular team consultation, including
video-based real-time supervision in both treatments.
Protocol violations will be reported to the therapists im-
mediately. Therapeutic training and experience of the
therapists will be balanced across treatment groups.
Therapists, training, and treatment adherence
At each of the three sites, therapists have been either
trained in DBT-PTSD or in CPT. DBT-PTSD therapists
at each site have been trained by the treatment devel-
opers, CPT therapists at each site have been trained by
Dr. Resick. Therapists were asked to videotape every ses-
sion. A randomly selected 2 of the 45 sessions of each
therapy are being evaluated with regard to treatment in-
tegrity. DBT-PTSD treatment adherence is evaluated by
using the DBT-PTSD Adherence Rating Scale, which
generates a global rating of DBT adherence as well as
sub-scale strategy ratings for various DBT-PTSD strategy
domains. CPT treatment adherence is evaluated using
the CPT Adherence Ratings Scale, which is based on the
adapted CPT treatment manual and orientated on the
original CPT Therapists’ Adherence Protocol – Revised
[84] and has been adapted to the present CPT manual
by R. Steil’s workgroup [76].
Assessments
Assessments will be conducted by blind raters at intake
and at months 3, 6, 9, 12, 15 (end of the treatment phase)
and at 1 year follow up. In addition to these assessments,
in DBT-PTSD weekly measurements will be completed in
the form of a daily diary card, rating of suicidal ideation,
non-suicidal self-injury, therapist notes, and pre- and
post-session ratings for each individual session.
Screening measures
Structured Clinical Interview for DSM-IV Axis I Disorders
(SCID-I; [85]); CAPS-5 [82, 83]; International Personality
Disorder Examination – Borderline section (IPDE; [86]);
SBDI [81]; Childhood Trauma Questionnaire (CTQ; [87]),
Maltreatment and Abuse Chronology of Exposure Scale
(MACE; [88]), Mehrfachwahl-Wortschatz-Intelligenztest
(MWT; [89]).
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Primary and secondary endpoints
The CAPS-5 [82, 83] will be used as the primary end-
point for testing hypotheses 1 and 2. In the first place
testing will be based on the dimensional CAPS-scores
assessed in the intent-to-treat sample. Secondary end-
points will include the Posttraumatic Stress Disorder
Checklist for DSM-5 (PCL-5; [90]) to assess self-rated
symptomatology of PTSD, the Dissociation Tension
Scale (DSS-7, [91]), the short version of the Borderline
Symptom List (BSL-23; [92]), the behavioural items of
the Borderline Symptom List [93] including suicide at-
tempts and non-suicidal self-injury, the BDI-II [70], and
the GAF [69].
Power analyses
The sample size was determined from a formal power
analysis. The study was designed to have sufficient statis-
tical power (1-β ≥ 0.80) to detect a supposed
medium-size superiority of DBT-PTSD over CPT for the
time*treatment interaction. A no more than medium
between-group effect-size (d = 0.5, which corresponds to
an effect-size f(V) of 0.354 for the time*treatment con-
trast for DBT-PTSD vs. CPT within a repeated measures
design) was assumed since CPT was supposed to be sub-
stantially more efficacious than the TAU-WL condition
to which DBT-PTSD has been previously compared.
Under these assumptions, data from 70 participants per
group are required to achieve sufficient statistical power
(1-β ≥ 0.80) for Hypothesis 1. For Hypothesis 2 (“the su-
periority of DBT-PTSD is related to the severity of
BPD-symptoms at baseline”) the power analysis indi-
cated that a sample-size of at least 90 per group is
needed to achieve sufficient statistical power to detect a
clinically meaningful incremental R2 of at least 0.1
within a regression model. Accordingly, the recruitment
target was set at a minimum of 180 participants (90 per
group) to be randomised. In order to recruit and treat a
minimum of 180 patients within 2 years, the study is
conducted at three large German centres: the Central
Institute of Mental Health in Mannheim, the Institute of
Psychology, Goethe University in Frankfurt, and the In-
stitute of Psychology, Humboldt University in Berlin.
Statistical analysis
The CAPS-5 and the assessments pertaining to the sec-
ondary hypotheses are obtained at baseline (=T1); at
month 3 (=T2); month 6 (=T3); month 9 (=T4); month
12 (=T5, end of high frequency phase); and month 15
(=T6, end low frequency phase = post assessment).
Mixed linear models including these assessment points
will be used as the primary analytic strategy to analyse
and compare the changes in the two groups. Parameters
will be estimated using restricted maximum likelihood
estimates (REML) and without imposing predefined
assumptions such as compound symmetry on the covari-
ance matrix. Analyses are based on the intent-to-treat
sample of patients who were randomised and fulfilled all
inclusion criteria. To provide a more complete picture
these primary analyses are complemented by analyses
comprising those participants who completed the study
according to protocol (ATP). To allow for a more com-
prehensive evaluation of the data, the results from the
mixed linear models are supplemented by clinically
meaningful indices including remission rates, response
rates and effect sizes.
Adjunct project I: Identifying key therapeutic components
and competence as predictors of outcome in DBT-PTSD
and CPT
Background
Treatment integrity, defined as the extent to which treat-
ment is implemented as intended, is not only required in
order to draw valid conclusions from clinical trials, but
is also implicated as a key ingredient of treatment suc-
cess [94, 95]. Treatment integrity includes 3 compo-
nents: 1) treatment adherence, which refers to the
degree of utilization of techniques as specified in a man-
ual, 2) treatment differentiation, which implies that
treatments in a study differ on relevant dimensions; and
3) therapeutic competence, which is defined as how well
these techniques are delivered and adapted to the spe-
cific therapeutic context [96].
In controlled clinical trials, it is currently standard
practice to control for treatment integrity by using ad-
herence ratings, but there are considerably fewer studies
assessing therapeutic competence and its relationship to
outcome [95, 97, 98]. With respect to established treat-
ments of PTSD, there are no published studies investi-
gating adherence and competence as predictors of
outcomes. One study investigated these variables in
gestalt-derived treatment for survivors of CA, but only
54% of the sample met PTSD DSM-IV criteria [99].
Competence here was not significantly related to
changes in interpersonal stress and emotional resolution;
it should be noted, however, that ratings were delivered
by non-expert raters. In contrast, previous trials with
other disorders [100, 101] indicate that competence is a
significant predictor of outcome and a better predictor
than adherence. In both studies, improved methods to
assess competence were used, which also covered spe-
cific treatment components.
Based on the finding that therapeutic alliance has been
more consistently found to correlate with treatment out-
come than competence correlates with treatment out-
come [102, 103], it has often been argued that common
factors may be more important than competences re-
lated to the specific treatment. However, findings from a
meta-analysis [98] suggest that therapeutic alliance may
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be considered as a moderator of the relationship be-
tween competence and outcome, as indicated by larger
effect sizes in studies that did not control for the influ-
ence of therapeutic alliance.
The present study aims at identifying therapeutic com-
petencies that are predictive for effective treatment of
PTSD, as well as its associations with adherence and alli-
ance. In addition, the present study provides the possi-
bility to compare two treatments, DBT-PTSD and CPT,
with respect to general aspects of competence common
to cognitive-behavioural treatments. Finally, the contri-
bution of particular components of general and specific
therapeutic competence to treatment response in both
treatments, will be subject to secondary, exploratory
analyses.
Hypotheses
1) Therapists’ general therapeutic competencies will
significantly predict treatment response (pre-post-
changes of CAPS) in both treatments.
2a) Therapists’ DBT-PTSD–specific competencies will
significantly predict treatment response at post-
treatment in DBT-PTSD.
2b) Therapists’ CPT–specific competencies will
significantly predict treatment response at post-
treatment in CPT.
We expect that both general (hypothesis 1) and spe-
cific competencies (hypotheses 2a and 2b) will con-
tribute significantly to the prediction of treatment
response at post-treatment when controlling for
pre-treatment severity of PTSD (pre-treatment scores
of the CAPS) and BPD (pre-treatment scores of
the BSL) as well as adherence and therapeutic alliance.
To test hypotheses 2a and 2b, general competencies
will also be controlled for.
Method
Assessments: Primary outcome measure will be the
CAPS-5 [83]. Therapeutic competence will be assessed
by two independent and extensively trained clinician
raters who are blind to treatment outcome, using rating
scales that have been specifically developed on the basis
of the manuals applied in this trial (i.e. [104]).
Observer ratings of competence and adherence will be
obtained from two randomly selected videotaped ses-
sions per patient, covering two different treatment
phases. The level of ratings averaged over the two phases
will enter the path analyses. To assess general competen-
cies, the Cognitive Therapy Scale [105] will be applied.
This scale comprises 15 items (e.g., homework, guided
discovery, efficient use of time, etc.). Items are rated on
a scale ranging from 0 to 6, referring to the quality of
implementation of interventions. The DBT-PTSD Compe-
tence Rating Scale [106] comprises 6 items referring to
components specific for DBT-PTSD, such as appropriate
implementation of skills. The CPT Competence Rating
Scale [104] comprises 4 items reflecting competencies
specific for CPT, such as identification of stuck points and
optimal application of worksheets. For both treatment
specific competence scales, items are rated on a scale from
0 to 6, and according to a detailed raters’ manual referring
to the quality of implementation of interventions.
Adherence ratings will be assessed using the
DBT-PTSD Adherence Rating Scale and the CPT Adher-
ence Rating Scale, respectively, which both have been
developed by our workgroup (i.e. [76]). To rate compe-
tence and adherence for one treatment session, on aver-
age 2 h are required.
All rating scales which have been developed to assess
treatment integrity of DBT-PTSD and CPT as used in
the present RCT have been evaluated for their psycho-
metric properties e.g., with respect to inter-rater reliabil-
ity (i.e., [76, 104]).
Therapeutic alliance will be assessed using the Helping
Alliance Questionnaire [107]. This rating scale is an
11-item questionnaire that assess therapeutic alliance
from both the patient’s and the therapist’s perspective.
For example the patients’ version consists of 11 subtypes
of patients’ helping alliances (e.g., the patient feels opti-
mism and confidence that the therapist can help; the pa-
tient shares with the therapist similar conceptions of the
aetiology of the problems). These components are rated
on a 6-point Likert scale.
Data analyses: Path analyses will be carried out to deter-
mine the effects of the predictor variables listed above.
For all hypotheses, differences in CAPS-5-scores at pre-
vs. post (T6) will be specified as the criterion variable.
For hypothesis 1, path analyses models with general
competencies as predictor variables will be specified.
For hypotheses 2a and 2b, path analyses models with
the specific therapeutic competencies as predictor vari-
ables will be specified. For all hypotheses, path analyses
models with pre-treatment severity of PTSD and BPD
(pre-treatment scores in the CAPS-5, pre-treatment
scores in the BSL) as well as therapeutic adherence and
therapeutic alliance as additional predictor variables
will be carried out. For hypotheses 2a and 2b, general
competence will also be included into the path analysis.
For hypothesis 1, a multi-sample path analysis with the
grouping variable treatment condition (DBT-PTSD vs.
CPT) will be performed. Path analyses allow us to spe-
cify correlations between predictor variables, and will
be carried out using Mplus version 7 [108]. Mplus of-
fers several advantages for data analysis, such as effect-
ive ways of missing value imputation (FIML) and
dealing with multi-level (nested) data.
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Adjunct project II: Experimental validation of therapy
response
Background
Besides psychometric measures, behavioural and neuro-
biological data can be used to validate treatment effects.
Several studies have shown that functional (and in part
also structural) alterations in PTSD are amenable to
change by psychotherapy [109]. While intrusions are
characterized by increased traumatic memory process-
ing, dissociation is related to reduced memory process-
ing up to amnesia [110]. Clinically, intrusions are
accompanied by physiological hyperarousal, while dis-
sociation is characterized by reduced arousal and, in ex-
treme cases, a shut-down of sensory and motor
processes. Dissociative responses have been shown to be
stress-related [111] and reduced startle responses during
dissociative states have been demonstrated [112]. The
interaction of dissociation and learning processes has
been investigated: Pavlovian conditioning was disturbed
during dissociation in patients with BPD [57], and dis-
sociation predicted poor outcome of standard DBT and
of DBT-PTSD [61, 113]. Recently, a neurobiological
model of PTSD has been proposed, differentiating pro-
cessing of intrusive hyperarousal as opposed to dissoci-
ation with emotional overmodulation [114]. Intrusive
responses are characterized by increased sympathetic ac-
tivity (elevated heart rate and blood pressure), whereas
dissociative responses are characterized by no change or
a decrease in heart rate [115]. On the neural level, sev-
eral studies have demonstrated amygdala hyperactivity
together with medial prefrontal hypoactivity [116–118]
to be associated with intrusive hyperarousal. On the
other hand, dissociative responses are characterized by
an increase in medial prefrontal and insular activity
[115, 119, 120]. Amygdala activity was negatively corre-
lated with dissociation levels during an Emotional Work-
ing Memory Task (EWMT; [121]). As intrusions and
dissociation interfere with attention, the Stroop task has
been widely used in PTSD. PTSD patients demonstrated
increased interference to trauma-related material in the
Emotional Stroop Task (EST; e.g., [122–124]). Imaging
studies have demonstrated over-activation in the dorsal
anterior cingulate cortex (dACC) as well as the insula in
PTSD related to sexual abuse [125, 126]. Psychotherapy
response was found to be related to a decrease of this
over-activation in sexual abuse-related PTSD [127].
Hypotheses
1a) Improvement of PTSD symptoms from pre to the
end of the high frequency phase of treatment
(ΔCAPS T1-T5) is correlated with the reduction of
dorsal ACC and anterior insula activity (ΔBOLD-
signal T1-T5) during trauma-related words in the
Emotional Stroop Task (EST).
1b) Improvement of PTSD symptoms from pre to the
end of the high frequency phase of treatment
(ΔCAPS T1-T5) is correlated with reduction of
amygdala activity and heart rate increase (ΔBOLD-
signal T1-T5) during negative pictures in the Emo-
tional Working Memory Task (EWMT).
2) Exploratively, we will investigate potential
differences regarding neural activation patterns
between DBT-PTSD responders and CPT re-
sponders. As DBT-PTSD includes skills-assisted
exposure, we assume that DBT-PTSD will have a
stronger effect on intrusions than will CPT. At the
neural level, we would therefore expect a stronger
reduction of the neural activation patterns of
intrusions in DBT-PTSD responders as compared
to CPT responders.
Power analyses for the hypotheses, i.e., that “Improve-
ment of PTSD symptoms is correlated with the reduc-
tion of i) dorsal ACC activity, ii) anterior insula activity,
iii) amygdala activity, iv) heart rate increase” are all
tested at the Bonferroni-adjusted level of α1 = 0.0125. A
large effect (r = 0.5) is assumed for the hypotheses. The
assumption of a large effect is in line with the results on
Emotional Stroop interference published by Thomaes et
al. [127] who found large correlations ranging from 0.64
and 0.74 between improvements on the CAPS and de-
creased activation of several regions including the dorsal
ACC and the anterior insula. Under these assumptions,
the sub-sample recruited at the Mannheim and Frank-
furt sites will be sufficient to achieve sufficient statistical
power of 1-β = 0.86 for rejecting each of the hypotheses
at the adjusted α-level of 0.0125 (two-tailed).
Method
Patients from both the DBT-PTSD and CPT arms who
have been recruited at Mannheim and Frankfurt will be
included in Adjunct project II, in which fMRI and la-
boratory measurements will be done before and after the
high frequency phase of the treatment. During fMRI, the
EST (20 words per valence; valence types: neutral, nega-
tive, trauma-related, colour words; each word presented
in four colours) will be conducted first. Following the
EST, the EWMT will be conducted, a working memory
task with neutral and negative distractors. Activity of
brain regions as assessed by the BOLD-responses as well
as sympathetic (heart rate) and parasympathetic activity
(heart rate variability) will be measured. Acute dissoci-
ation will be assessed with the Dissociation Tension
Scale (DSS-4; [128]) intrusions will be assessed with the
subscale “Intrusions” of the Impact of Event Scale- Re-
vised (IES-R; [129]). Imaging data will be acquired using
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a 3 Tesla MRI Scanner (TRIO, Siemens Medical Sys-
tems, Erlangen, Germany). Neural activation patterns
will be correlated with dissociation and intrusion scores
within a multiple regression analysis using SPM 8
(http://www.fil.ion.ucl.ac.uk/spm/).
Discussion
We have designed DBT-PTSD as the first treatment
programme specifically designed for cPTSD related to
childhood abuse. A first RCT revealed large between group
effect sizes as compared to treatment-as-usual under resi-
dential conditions. The study on hand is aimed to compare
the newly designed treatment with an established evidence
based state of the art programme – CPT. In addition to
treatment effectiveness and efficacy, this study will provide
a large data set of including 200 patients with 6 assessment
points plus follow up. This will open the opportunity to en-
large our knowledge about the complexity and interrelated-
ness of psychopathology, neurocognitive patterns and
neuroimaging. Considering the fact, that cPTSD is a new
ICD-11 diagnosis, there is not only a strong need to under-
stand predictors, moderators and mediators of treatment
response, but to create hypotheses of differential treatment
response to exposure based or pure cognitive treatments.
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